Skip to content

The Medical Minute: New menopause guidelines support hormone replacement for hot flashes and night sweats

When hot flashes suddenly began disrupting Rebecca G.’s life, menopause wasn’t the first thing on her mind.

The Elizabethtown resident had a hysterectomy when she was 32 and hadn’t had a period in years.

“I wasn’t really paying attention to my cycle. I had no idea whether I was in menopause or not,” she says. “Then out of nowhere, when I was 50, I started having hot flashes all the time, several times a day and at night.”

Looking for relief, Rebecca went to her primary care physician, but he wasn’t familiar with hormone replacement therapy (HRT) or comfortable prescribing it for menopause symptoms. A coworker recommended Penn State Health’s Menopause Clinic, led by Dr. Cynthia Chuang, a women’s health and internal medicine physician at Penn State Health Cocoa Outpatient Center.

After talking with Rebecca, Chuang prescribed an estrogen patch. Within weeks, Rebecca noticed fewer hot flashes. She’s now been using the patches for a year and will continue to check in annually to make sure the treatment is still right for her.

Rebecca’s experience comes as the American College of Obstetricians and Gynecologists released new guidelines recommending HRT as a first-line treatment for hot flashes and other vasomotor symptoms. The guidelines also recommend alternative treatments for women who can’t or prefer not to use hormones.

The American College of Obstetricians and Gynecologists emphasizes working with patients to determine when to start and stop HRT and whether the benefits outweigh the risks. Typically, women who use HRT begin before age 60 or within 10 years of the start of spontaneous menopause.

Chuang says the guidelines are a big step in a positive direction.

“They did a comprehensive review of the research and literature around vasomotor symptoms and sleep disturbances related to vasomotor symptoms,” Chuang says. “This really elevates it and says that unless you have risk factors that don’t allow you to take hormone therapy for some reason, they recommend systemic menopausal hormone therapy.”

Learn more about Penn State Health’s menopause care.

What Changed with Hormone Replacement Therapy?

HRT was widely used before the Women’s Health Initiative released findings in 2002 linking the estrogen-plus-progestin treatment studied with increased risks of breast cancer, cardiovascular disease, stroke and pulmonary embolism. Those findings led to black box warnings on hormone therapy products about the risk of heart attack, dementia and breast cancer and changed the way physicians and patients viewed HRT. Its use declined sharply, and many physicians turned to nonhormonal treatments for menopause symptoms.

But researchers continued to study the risks and benefits of hormone therapy, including how a woman’s age and timing of treatment may affect them.

In November 2025, after reviewing more recent research, the U.S. Food and Drug Administration requested that drug manufacturers remove references to cardiovascular disease, breast cancer and probable dementia from the boxed warnings on menopausal hormone therapy products. The agency approved updated labeling for the first products in February 2026. Some information about potential risks remains elsewhere in the labeling, and a boxed warning about endometrial cancer remains for systemic estrogen-only products.

The shift continued in 2026. The American College of Obstetricians and Gynecologists’ new guidelines recommend HRT as a first-line treatment for hot flashes and other vasomotor symptoms. In October, the American College of Physicians also endorsed hormone therapy as a first-line treatment for hot flashes and night sweats.

Find a Penn State Health obstetrician-gynecologist near you.

More Options for Relief

Chuang says support for hormone replacement therapy from both the American College of Physicians and the American College of Obstetricians and Gynecologists means more physicians will know what to do when their patients describe hot flashes, even if they don’t primarily treat menopause symptoms.

“The American College of Obstetricians and Gynecologists statement tells OB-GYNs that hormone replacement therapy is part of their standard of care,” she says. “The American College of Physicians statement is telling internists the same thing. This is part of what we do.”

HRT isn’t the only option. In the updated guidelines, several nonhormonal options are still recommended, including certain antidepressants, neurokinin receptor agonists like fezolinetant and elinzanetant (marketed as Veozah and Lynkuet in the U.S.) and non-pharmacological treatments like meditation, cognitive behavioral therapy, acupuncture and hypnosis.

Chuang notes that the new guidelines only address vasomotor symptoms. Research is still not conclusive enough to support recommending HRT for symptoms like mood disorders or other menopausal symptoms.

Schedule a virtual appointment at the Penn State Health Menopause Clinic: 833-948-1103

Science Over Hype

Having an evidence-based option to turn to is particularly important in the age of social media, Chuang says. As the menopause marketing machine amps up, many are turning to over-the-counter supplements that may not deliver on their big promises. The Menopause Society, American College of Obstetricians and Gynecologists and American College of Physicians guidelines all warn that unregulated herbal supplements lack clinical evidence to support their use.

“Many women come to me when they’re already on supplements. I’m not here to say they are doing something wrong, and they can still choose to take them,” Chuang says. “But I do tell them that there’s no evidence that they are beneficial, and to be wary of influencers, including health care providers, selling supplements for their own financial gain.”

Many menopause supplements on the market now can also be expensive and are promoted by prominent physicians in the menopause sphere. Chuang urges patients to follow the science, not the hype. As the medical community turns back to embracing HRT, more women like Rebecca have evidence-based options for managing their menopause symptoms.

Related content:

The Medical Minute is a weekly health news feature produced by Penn State Health. Articles feature the expertise of faculty, physicians and staff, and are designed to offer timely, relevant health information of interest to a broad audience.

If you're having trouble accessing this content, or would like it in another format, please email Penn State Health Marketing & Communications.